Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2008 | 2013 | ||||||||
|
atypical chemokine receptor 2 | 0.641 | 0.615 | 1.4E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
ADAM metallopeptidase domain 10 | 0.489 | 0.846 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 13 | 0.496 | 0.769 | 5.1E-15 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
adrenomedullin | 0.436 | 0.808 | 4.1E-02 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
adenosine A2a receptor | 0.526 | 0.769 | 0.60 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
adenosine A2b receptor | 0.617 | 0.692 | 1.8E-05 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
albumin | 0.317 | 0.962 | 0.64 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2017 | 2018 | ||||||||
|
alpha-1-microglobulin/bikunin precursor | 0.537 | 0.731 | 2.8E-13 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
angiopoietin 1 | 0.446 | 0.808 | 0.95 |
|
disease | 0.320 | None | 1.000 | 3 | 0 | 2005 | 2019 | ||||||||
|
angiopoietin 2 | 0.410 | 0.846 | 0.83 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2015 | 2019 | ||||||||
|
alanyl aminopeptidase, membrane | 0.462 | 0.769 | 3.7E-09 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
apolipoprotein M | 0.590 | 0.769 | 9.6E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
aquaporin 5 | 0.552 | 0.769 | 5.3E-02 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2011 | 2016 | ||||||||
|
AT-rich interaction domain 5A | 0.821 | 0.269 | 0.95 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
arylsulfatase L | 0.663 | 0.654 | 0.59 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
azurocidin 1 | 0.636 | 0.692 | 3.9E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2004 | 2011 | ||||||||
|
BCL2 like 11 | 0.510 | 0.731 | 0.89 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
BH3 interacting domain death agonist | 0.555 | 0.808 | 1.6E-11 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
bactericidal permeability increasing protein | 0.610 | 0.769 | 1.7E-14 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
BTB domain containing 8 | 0.547 | 0.692 | 6.1E-07 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2012 | 2018 | ||||||||
|
complement C3a receptor 1 | 0.601 | 0.731 | 3.3E-09 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 |